The scope of the report is to highlight and gauge existing technologies in the production of therapeutic mAbs. The report also discusses key insights on interchangeability and substitution of therapeutic antibodies and biosimilars.
Further, there is also an assessment of the current drivers and restraints that affect the uptake of biosimilars.
The report answers key questions that are paramount for understanding the ... Read more
Meticulous Research® – a leading global market research company published a research report titled “Cancer Immunotherapy Market by Type (Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy), Application (Lung, Breast, Multiple Myeloma, Colorectal, Melanoma, Prostate), and End User– Global Forecast to 2024“. ... Read more
Cancer has plagued humankind for centuries and taken countless lives. However, with persistent scientific research and advances in medical technology, our understanding of cancer and ability to treat it has increased dramatically in recent decades. One area that has seen tremendous progress is cancer biologics - biological agents designed to harness the body's own immune system to fight cancer in innovative ways.
What are Cancer Biologics?
Cancer biologics ... Read more
Biologics such as monoclonal antibodies, recombinant proteins, gene and cellular therapies have rapidly transformed the treatment landscape in recent years. These complex large molecule drugs are usually produced through biological processes in a living system such as a microorganism or cell culture. Some key benefits of biologics include high specificity and ability to target the underlying disease pathology more precisely ... Read more
